High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy. - Wikidata - awgldk - TriplyDB

High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy.

High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy.

http://www.wikidata.org/entity/Q34444002

about

Predictors of tuberculosis in first 6 months after initiation of antiretroviral therapy: a case-control study High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study.Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar Collaborative activities and treatment outcomes in patients with HIV-associated tuberculosis in Viet Nam Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis.Clinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting.Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014.Successes and challenges of HIV treatment programs in Haiti: aftermath of the earthquake Tuberculosis as part of the natural history of HIV infection in developing countries Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India.Duration of anti-tuberculosis therapy and timing of antiretroviral therapy initiation: association with mortality in HIV-related tuberculosis.Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening.Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening Natural History and Factors Associated with Early and Delayed Mortality in HIV-Infected Patients Treated of Tuberculosis under Directly Observed Treatment Short-Course Strategy: A Prospective Cohort Study in India.Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.HIV and co-infections.Predictors of Survival in HIV-Infected Patient after Initiation of HAART in Zewditu Memorial Hospital, Addis Ababa, Ethiopia.Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy.Diagnostic and Prognostic Value of Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy: Datafrom an HIV Cohort Study in India.Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.Burden of disease and risk factors for death among children treated for tuberculosis in Malawi.Management of individuals requiring antiretroviral therapy and TB treatment.Reducing the burden of tuberculosis presenting during the initial months of antiretroviral therapy in resource-limited settings.Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis.Prognostic indicators in the World Health Organization's algorithm for seriously ill HIV-infected inpatients with suspected tuberculosis.Predicting death and lost to follow-up among adults initiating antiretroviral therapy in resource-limited settings: Derivation and external validation of a risk score in Haiti

P2860

Q28397102-49B7AFA6-8B67-4645-9F8B-09464CAC306C Q30061805-351277FB-BE34-4351-B238-B7857816DEF6 Q30383131-A0BF1561-45A0-46C8-B332-CCC71065EA90 Q30385262-BEFFD628-8A3B-4D58-85E6-90358516D346 Q30666504-35B8AAA9-3431-449E-A63C-144BD997E209 Q30993875-0B74A7CC-2AD4-439B-AF19-D447E00FF795 Q33390898-9259020B-E9DC-4C70-8CA8-CCAF08DCE826 Q33777533-5EDD7DA2-7FA1-4A40-BAB5-D0A84D74C351 Q34446995-47F85C13-E64A-4AB2-88A2-1B708CA57435 Q34547644-CB1DCFA9-46DE-4137-81A3-7BAC5C0F7477 Q34675209-59BFD974-9A0D-4412-9FA5-87C34540DB46 Q34997183-208FCEAC-0A3B-470F-835C-DAC9AD944DF4 Q35023340-2D202678-0F8B-4BFC-A4F1-CCC43181D692 Q35167106-F708D062-3345-46FF-B2BA-145725F03145 Q36505791-37503AD5-BC2D-4046-A0D4-30CC068F6B00 Q36934339-CDE1F49E-7362-411A-B6EA-3C831F9A5897 Q36970184-18EB7FB2-C40A-406D-A628-7244CA731FCF Q36980035-35E03D8B-7E24-4A83-A444-5240054B0493 Q37061089-18A56997-AE7E-4559-A2BA-90E167ED6C99 Q37168581-3A43F669-72A2-4DE0-97E6-B3D9F0F0AB94 Q37168588-8C34694B-4D84-48B5-81E0-2021236AF0D6 Q37207071-ECFAF1FF-5689-4856-A41C-C7AC4A0EE810 Q37505042-235D59D6-8D83-4DE2-8505-675882A84082 Q37639897-A05C5D52-1DEF-4E64-ACA4-1465389BDEEF Q37666456-E6AC7195-32BB-402F-A9B3-73C7A06FBF97 Q42937515-87668180-48BF-4D44-9EB1-18670FADCB43 Q47105244-BD949459-81C6-47B8-AB45-589B98D8B5CB Q49243354-4786168B-D2C8-4205-859E-C4115EBFA5F7 Q58696535-576351BE-D5C4-429D-ABDC-E966D4696343

P2860

High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy.

http://www.wikidata.org/entity/Q34444002

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

High mortality among patients ...... ths of antiretroviral therapy.

@ast

High mortality among patients ...... ths of antiretroviral therapy.

@en

High mortality among patients ...... ths of antiretroviral therapy.

@nl

type

label

High mortality among patients ...... ths of antiretroviral therapy.

@ast

High mortality among patients ...... ths of antiretroviral therapy.

@en

High mortality among patients ...... ths of antiretroviral therapy.

@nl

prefLabel

High mortality among patients ...... ths of antiretroviral therapy.

@ast

High mortality among patients ...... ths of antiretroviral therapy.

@en

High mortality among patients ...... ths of antiretroviral therapy.

@nl

P1433

Q34444002-DA30A3E5-1EE7-4E88-B3B2-E0572505306A

P1476

Q34444002-C22D6B5C-428C-4777-83A8-84615EE3DB37

P2093

Q34444002-5313C7AE-5FEF-4F95-81B0-642C86B01465

Q34444002-8E9F4DD3-6C66-40CE-8FF1-6CE14120C6AE

Q34444002-A1280C82-B63B-40E9-9011-A31611D101D8

Q34444002-C616DBF9-EC3A-4E7F-85E2-F0E72BB6E5B3

Q34444002-D1AB9BD9-2099-4552-8B50-CD0EBB7BB1C6

Q34444002-DE04881B-56EF-4150-853D-4B91FD664FAC

P2860

Q34444002-41188661-59B1-4567-B8C2-853DFE941FD6

Q34444002-806A4912-6BFA-4216-862D-EA0D1FAF5D11

Q34444002-90C0082E-22BC-46A1-BFB5-3CD12EC5ACC6

Q34444002-A2A5E82B-BC84-45A8-B971-186C52541115

Q34444002-AA078E8D-26BD-46BA-BAF6-312D04650C5B

Q34444002-AEFDC23C-1B9B-46FC-AA1D-15731B0436D7

Q34444002-B7EF99CE-611F-4D0D-B39C-E9377B282BEE

Q34444002-C792C8AB-5D02-476E-9CA1-F31BA70EFAEB

Q34444002-EC163B03-E3C0-4307-9A71-35BB507DD34C

Q34444002-FC6C9AB6-FAF7-4BED-A433-A7CF0E6FA660

P304

Q34444002-2DC9A932-A782-4556-A322-2732A6A94D8F

P31

Q34444002-D357703A-F108-4BF7-A146-DE3E98BD0108

P356

Q34444002-5F578C36-3469-47F0-9A31-8C992C88A237

P407

Q34444002-D2262D75-BEE0-49CF-A986-C67DF7AEA86C

P433

Q34444002-1A0CC7F5-C428-49A0-865E-4F4EF7BF92A7

P478

Q34444002-9A49927D-6BA3-4CC9-ACD0-123501F574EC

P50

Q34444002-0639F031-3E7C-4A82-A39A-35BDA7B4F8DD

Q34444002-B5022A8F-89A4-4BEE-8841-C74B73007812

Q34444002-C9175623-B5DC-472D-AAE2-E232A2246E2D

Q34444002-E9B9ABA9-9D90-4025-BA96-1A875520107A

P577

Q34444002-07C54EDE-4E0C-4A3E-8B92-4A179B185E37

P5875

Q34444002-7967F5EB-A399-410D-9D2D-049F96DD6A76

P698

Q34444002-CFE5D21C-B764-4081-BE7E-04F715031387

P921

Q34444002-35EF1A76-1160-47D9-946C-D8D8D31EF1E4

Q34444002-66066C14-F785-470F-A690-E78837718690

Q34444002-B40E381B-B719-4056-8F28-67D7254FC10E

P932

Q34444002-3F35E4D7-3E35-4174-A90F-8F77CFC49379

P356

P1433

Clinical Infectious Diseases

P1476

High mortality among patients ...... ths of antiretroviral therapy.

@en

P2093

Cynthia Riviere

http://www.w3.org/2001/XMLSchema#string

Erin Lee

http://www.w3.org/2001/XMLSchema#string

Kea Parker

http://www.w3.org/2001/XMLSchema#string

Paul Leger

http://www.w3.org/2001/XMLSchema#string

Sean Collins

http://www.w3.org/2001/XMLSchema#string

Serena P Koenig

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of tuberculosis

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy.

Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.

Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes.

Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.

Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.

Antiretroviral therapy in a thousand patients with AIDS in Haiti.

Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial.

Outcomes of tuberculosis patients who start antiretroviral therapy under routine programme conditions in Malawi.

P304

829-831

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/597098

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Jean William Pape

Daniel W Fitzgerald

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23997628

http://www.w3.org/2001/XMLSchema#string

P698

19207078

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

antiretroviral drug

P932

3010922

http://www.w3.org/2001/XMLSchema#string